Apr 182014

Significant Impact of New EU Data Protection Regulation on Financial Services

William RM Long
, ,

Global Banking & Finance Review

Over two years ago, in January 2012, the European Parliament published a proposal for an EU Regulation on Data Protection (the Regulation) to replace the current European Data Protection Directive. Whilst the Regulation raises significant issues for all industries, the financial services sector has been particularly concerned given the billions of financial records and transitions handled yearly. Due to its potential impact, the proposed Regulation has been one of the most lobbied pieces of European legislation in European Union history. According to reports, the European Parliament’s Civil Liberties Committee, which has been negotiating the Regulation, has received over 4,000 amendments.

View Article

William RM Long

London

wlong@sidley.com

You might also like
UK’s New Pro-innovation Approach to Regulating Digital Technologies

On 15 March 2023, the UK Government published, alongside its Spring Budget, a report on the Pro-innovation Regulation of Technologies Review (the “Report”). The Report was led by the government’s Chief Scientific Advisor and National Technology Officer, Sir Patrick Vallance, who was tasked with “bringing together the best minds to advise how the UK can better regulate emerging technologies, enabling their rapid and safe introduction.” In response, the UK Government has accepted all of the Report’s recommendations, and set out some next steps for their implementation.

Substantial Changes to Hong Kong’s Privacy Laws Coming

In a briefing to the Legislative Council (Hong Kong’s legislative body) on February 20, 2023, the Privacy Commissioner (“the Commissioner”) announced that substantive amendments to the Personal Data (Privacy) Ordinance (“PDPO”) will take place.

It Is Now More Difficult For International Pharma To Transfer Data Out Of China

China’s new Measures for the Security Assessment of Outbound Data Transfers (the “Measures”) came into force on September 1, 2022. Pharma companies now have until February 28 to work out whether their activities mean they are affected, and to apply for the new type of data security assessment if they need it.